clofibrate has been researched along with penicillamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Forster, PJ; McConkey, B | 1 |
| Bird, HA; Dixon, JS; Martin, MF; Pickup, ME; Sitton, NG; Surrall, KE | 1 |
| Dingle, JT; Hazleman, B; Pilsworth, LM; Sheppeard, H | 1 |
| Dennery, PA | 1 |
2 review(s) available for clofibrate and penicillamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological interventions for the treatment of neonatal jaundice.
Topics: Agar; Bilirubin; Charcoal; Clofibrate; Drugs, Chinese Herbal; Heme; Humans; Infant, Newborn; Jaundice, Neonatal; Liver Circulation; Metalloporphyrins; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Penicillamine; Phenobarbital; Treatment Outcome | 2002 |
6 other study(ies) available for clofibrate and penicillamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antigen-Antibody Complex; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Clofibrate; Complement Activating Enzymes; Complement C1q; Drug Therapy, Combination; Female; Gold; Humans; Male; Methylprednisolone; Middle Aged; Penicillamine; Prednisolone; Sulfasalazine | 1986 |
The effect of drugs on serum histidine levels in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Captopril; Clofibrate; Drug Combinations; Female; Histidine; Humans; Hydroxychloroquine; Male; Middle Aged; Penicillamine; Sulfates; Trientine; Zinc; Zinc Sulfate | 1983 |
Effects of antirheumatoid drugs on the production and action of porcine catabolin.
Topics: Animals; Aspirin; Cartilage; Cattle; Chloroquine; Chondroitin Sulfates; Clofibrate; Culture Techniques; Dose-Response Relationship, Drug; Glycine; Gold Sodium Thiomalate; Interleukin-1; Interleukin-1beta; Penicillamine; Prednisolone; Protein Biosynthesis; Swine; Synovial Membrane | 1982 |